Cargando…

Comparison of three serological chemiluminescence immunoassays for SARS-CoV-2, and clinical significance of antibody index with disease severity

BACKGROUND: The clinical significance of the quantitative value of antibodies in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains mostly unidentified. We investigated the dynamics and clinical implications of the SARS-CoV-2 antibody over time using three automated chemi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Nuri, Jeong, Seri, Park, Min-Jeong, Song, Wonkeun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241106/ https://www.ncbi.nlm.nih.gov/pubmed/34185813 http://dx.doi.org/10.1371/journal.pone.0253889

Ejemplares similares

Serological chemiluminescence immunoassay for the diagnosis of SARS‐CoV‐2 infection
por: Lijia, Shao, et al.
Publicado: (2020)

Chemiluminescence Immunoassay Based Serological Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Vaccinated Population
por: Yin, Qiangling, et al.
Publicado: (2021)

Diagnostic Accuracy of Electro-Chemiluminescence Immunoassay Anti-SARS-CoV-2 Serological Test
por: Afzal, Nayab, et al.
Publicado: (2021)

Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies
por: Parai, Debaprasad, et al.
Publicado: (2021)

Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
por: Lee, Nuri, et al.
Publicado: (2022)

Evaluation of the analytical performance of three chemiluminescence serological assays for detecting anti-SARS-CoV-2 antibodies
por: Lo Sasso, Bruna, et al.
Publicado: (2022)

Seven-Month Analysis of Five SARS-CoV-2 Antibody Assay Results after ChAdOx1 nCoV-19 Vaccination: Significant Decrease in SARS-CoV-2 Antibody Titer
por: Jeong, Seri, et al.
Publicado: (2021)

STANDARD M10 SARS-CoV-2 Assay for Rapid Detection of SARS-CoV-2: Comparison of Four Real-Time PCR Assays
por: Jeong, Seri, et al.
Publicado: (2022)

Chemiluminescence Immunoassay to Detect Anti‐HTLV‐I Antibodies
por: Kamihira, Shimeru, et al.
Publicado: (1993)

SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia
por: Sekirov, Inna, et al.
Publicado: (2021)

Quantitative Analysis of Anti-N and Anti-S Antibody Titers of SARS-CoV-2 Infection after the Third Dose of COVID-19 Vaccination
por: Lee, Nuri, et al.
Publicado: (2022)

Humoral and Cellular Responses to BNT162b2 as a Booster Following Two Doses of ChAdOx1 nCov-19 Determined Using Three SARS-CoV-2 Antibody Assays and an Interferon-Gamma Release Assay: A Prospective Longitudinal Study in Healthcare Workers
por: Jeong, Seri, et al.
Publicado: (2022)

Automated detection of neutralizing SARS-CoV-2 antibodies in minutes using a competitive chemiluminescence immunoassay
por: Klüpfel, Julia, et al.
Publicado: (2022)

Comparison of three automatic chemiluminescent immunoassays for monitoring dynamic profile of SARS‐CoV‐2 IgG and IgM
por: Dou, Xiaowen, et al.
Publicado: (2020)

Immature granulocyte percentage for prediction of sepsis in severe burn patients: a machine leaning-based approach
por: Jeon, Kibum, et al.
Publicado: (2021)

Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis
por: Liu, Wanbing, et al.
Publicado: (2020)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodies
por: Gaber, Yasmine, et al.
Publicado: (2022)

Performance verification of anti-SARS-CoV-2-specific antibody detection by using four chemiluminescence immunoassay systems
por: Wan, Yafang, et al.
Publicado: (2020)

A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients
por: Grossberg, Allison N., et al.
Publicado: (2021)

Evaluation of Two Chemiluminescent and Three ELISA Immunoassays for the Detection of SARS-CoV-2 IgG Antibodies: Implications for Disease Diagnosis and Patients’ Management
por: Speletas, Matthaios, et al.
Publicado: (2020)

Comparison and evaluation of Abbott chemiluminescent microparticle immunoassay and ChIVD light‐initiated chemiluminescent assay in the detection of Treponema pallidum antibody
por: Chen, Xiaohui, et al.
Publicado: (2020)

Clinical diagnostic performance of light‐initiated chemiluminescent assay compared with the Architect chemiluminescence immunoassay for detection of HCV antibody
por: Yang, Shuo, et al.
Publicado: (2019)

The performance of the chemiluminescent immunoassay for measuring serum myeloperoxidase and proteinase 3 antibodies
por: Hou, Xiuzhu, et al.
Publicado: (2020)

Clinical Assessment of the DiaSorin LIAISON SARS-CoV-2 Ag Chemiluminescence Immunoassay
por: Salvagno, Gian Luca, et al.
Publicado: (2021)

The Detection of SARS-CoV2 Antigen in Wastewater Using an Automated Chemiluminescence Enzyme Immunoassay
por: Thongpradit, Supranee, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2
por: Cerino, Pellegrino, et al.
Publicado: (2021)

An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccinees
por: Liu, Binjian, et al.
Publicado: (2022)

Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan
por: Chen, Shey-Ying, et al.
Publicado: (2020)

Performance of an automated chemiluminescent immunoassay for SARS-COV-2 IgM and head-to-head comparison of Abbott and Roche COVID-19 antibody assays
por: CS, Lau, et al.
Publicado: (2021)

Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
por: Weber, Myriam C., et al.
Publicado: (2021)

Serological diagnosis of SARS-CoV-2: Diagnostic rentability of a chemiluminescence test()
por: Infante Urrios, Ana, et al.
Publicado: (2021)

Deep learning application of the discrimination of bone marrow aspiration cells in patients with myelodysplastic syndromes
por: Lee, Nuri, et al.
Publicado: (2022)

Comparison of Six Serological Immunoassays for the Detection of SARS-CoV-2 Neutralizing Antibody Levels in the Vaccinated Population
por: Lee, Hee-Jung, et al.
Publicado: (2022)

Development of magnetic particle-based chemiluminescence immunoassay for measurement of SARS-CoV-2 nucleocapsid protein
por: Xu, Ye, et al.
Publicado: (2022)

Currently Applied Molecular Assays for Identifying ESR1 Mutations in Patients with Advanced Breast Cancer
por: Lee, Nuri, et al.
Publicado: (2020)

Currently Used Laboratory Methodologies for Assays Detecting PD-1, PD-L1, PD-L2 and Soluble PD-L1 in Patients with Metastatic Breast Cancer
por: Jeong, Seri, et al.
Publicado: (2021)

Development and validation of a deep learning-based protein electrophoresis classification algorithm
por: Lee, Nuri, et al.
Publicado: (2022)

Changing Genotypic Distribution, Antimicrobial Susceptibilities, and Risk Factors of Urinary Tract Infection Caused by Carbapenemase-Producing Pseudomonas aeruginosa
por: Jeong, Seri, et al.
Publicado: (2024)

Comparison of 16 Serological SARS-CoV-2 Immunoassays in 16 Clinical Laboratories
por: Harritshøj, Lene H., et al.
Publicado: (2021)

Performance of two rapid point of care SARS-COV-2 antibody assays against laboratory-based automated chemiluminescent immunoassays for SARS-COV-2 IG-G, IG-M and total antibodies
por: Lau, C.S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sgopdbm4nfjvogerld4cthiljp